等待開盤 03-26 09:30:00 美东时间
+1.310
+3.49%
Marex Group plc filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission on March 25, 2026. The full report is available on Marex's website at https://ir.marex.com/financials/annual-reports. Shareholders can request a hard copy of the annual report, containing audited consolidated financial statements, by emailing investors@marex.com. Marex provides market access, infrastructure...
03-25 21:46
Marex flags oil market volatility as Kharg Island strikes threaten 20 million b/d Hormuz flows Marex reported that escalating Iran–US tensions have increased oil market volatility, with US strikes near Iran’s Kharg Island highlighting risks to export infrastructure that handles about 90% of Iran’s s
03-17 17:40
今日重点评级关注:古根海姆:维持Dianthus Therapeutics"买入"评级,目标价从100美元升至200美元;HC Wainwright & Co.:维持Amylyx Pharmaceuticals"买入"评级,目标价从28美元升至34美元
03-05 13:56
Barclays analyst Benjamin Budish maintains Marex Group (NASDAQ:MRX) with a Overweight and raises the price target from $49 to $50.
03-04 22:52
Marex Group (NASDAQ:MRX) released its Q4 earnings on Tuesday, March 3, 2026 at ...
03-03 20:02
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is expected to rep...
03-03 19:11
<p>Marex Group announced the agreement to acquire Webb Traders, enhancing its equity derivatives market making capabilities. Webb Traders, with offices in Amsterdam and Paris, specializes in single stock options market making for European and US mid to large cap equities. The acquisition brings a technology-driven team and electronic trading capabilities aligned with Marex's risk management approach. It is expected to strengthen Marex’s Equity Li...
02-06 12:00
今日重点评级关注:HC Wainwright & Co.:维持Rezolve AI"买入"评级,目标价从10美元升至12美元;HC Wainwright & Co.:维持Largo"买入"评级,目标价从2.9美元升至3.1美元
01-15 16:10
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
Barclays analyst Benjamin Budish maintains Marex Group (NASDAQ:MRX) with a Overweight and lowers the price target from $50 to $49.
01-09 05:08